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Background: Little is known about contextual effects on chronic pain, and how vulnerability factors influence pain
in different contexts. We wanted to examine if fibromyalgia (FM) pain varied between two social contexts, i.e. at
home versus in a doctor office, when it was measured the same day, and if pain was stable for 14 years when
measured in similar contexts (doctor office). Our secondary aim was to explore if pain vulnerability factors varied in
the two different contexts.
Findings: Fifty-five female FM patients were included in the study and scored pain in both contexts at baseline.
Their age ranged between 21–68 years (mean 45.7), mean education level was 11 years and mean FM-duration was
15.6 years. Their mean pain was perceived significantly lower at home than in a doctor context the same day.
However, pain was much more stable when measured in two similar contexts 14 year apart where 30 subjects
(54.5%) completed. Predictor analyses revealed that pain vulnerability factors apparently varied by home and
doctor contexts.
Conclusion: Pain and pain predictors seem to vary by contexts and time, with less pain at home than to a doctor
the same day, but with unchanged pain in the same context after 14 years. Thus, contextual pain cues should be
accounted for when pain is measured and treated, e.g. by focusing more on home-measured pain and by
optimizing the doctor office context. This explorative study should be followed up by a larger full-scale study.
Keywords: Fibromyalgia, Chronic pain, Context, Time, Long-term, Cohort, ExplorativeFindings
Fibromyalgia (FM) is a disorder characterized by chronic,
widespread pain (CWP) with increased sensitivity for
mechanical pressure in at least 11 out of 18 defined ten-
der points (TP) [1]. FM is associated with female gender,
low income and education, fatigue, irritable bowel and
bladder symptoms, headache, negative mood and sleep-
lessness [2,3], previous pain [4] and stress induced HPA
axis reactivity [5]. The prognosis is uncertain, and there
are few and inconclusive prospective studies. FM pain ap-
pear stable from two to ten years in some natural course
studies [6-13], while others demonstrate aggravation [14],
improvement [15] or mixed aggravation and improve-
ment [16]. Long-term follow-ups after psychological* Correspondence: eafors@online.no
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reproduction in any medium, provided the orinterventions have shown small effects on pain, but im-
provement in quality of life (QoL) [17]. Guided imagery
has improved FM pain in the short term [18], but not in
the long-term [19]. Cognitive behavioral therapy (CBT)
has improved worry, pain behavior, pain coping, depression
and reduced healthcare-seeking behavior in prospective
studies [20,21].
According to the neuromatrix pain theory, the percep-
tion of pain is dynamically influenced by emotions,
motivations, memory and other sensory and homeostatic
inputs [22-24]. Thus, pain is always experienced in a
context and influenced by it [25]. Context affects a var-
iety of health measures including blood-pressure, which
appears lower at home than to a doctor [26,27]. Also
memory and learning [28] as well as anxiety and fear-
conditioning [29,30] are affected by context. The impact
of contextual factors for the experience of pain has been
demonstrated in brain imaging studies and laboratory
experiments [31,32]. For example, animal studies have. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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contexts [33,34].
In a Norwegian study, healthy males reported less
laboratory pain in a context with female investigators,
compared to a context with male investigators, while
females reported the same pain regardless of the
investigators’ gender [35]. Perhaps the most obvious
example of context influencing pain is the discrepancy
observed in clinical and experimental contexts [36].
However, there are few studies investigating variations
in the reporting of pain by contextual factors among
patients with chronic pain. In one study, variations in
weather were related to daily variations in pain among
FM patients [37]. Other studies have shown that the
social contexts are important for the acceptance of
chronic pain [38] and the appraisals of pain threats [39].
In this study we monitored a cohort of female FM
patients where pain was measured at home and in a
doctor office the same day (baseline) and reexamined
14 years later. Our main research question was to
examine if pain was context-dependent or time-
dependent, i.e. if pain would vary by two different social
contexts in one day and by a 14 years’ time lag from
baseline to follow-up in one context. As a secondary aim
we wanted to investigate if vulnerability factors were
associated with pain in the different contexts and time
points.Eligible (n= 63 )
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with predictor analyse
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Figure 1 A CONSORT-diagram of the study design. FU = Follow-up.Methods
Design
This study is a prospective cohort with an explorative
design, and the patients were followed from baseline in
August 1991- May 1992 to follow-up in August 2005,
and thus had no Clinicaltrials.gov number.
Participants
55 female subjects were classified and found eligible for
this study according to the American College of
Rheumatology (ACR) criteria for FM, including chronic
widespread pain (CWP) with at least 11 out of 18 specified
tender points [1]. The women’s age at baseline ranged be-
tween 21–68 years (mean 45.7) and their mean education
level was 11 years and their mean FM-duration was 15.6
years [26]. 14 years later, 30 of these 55 (54.5%) showed up
to measure pain and other parameters after having been
invited to a meeting after formal information; 15 refused
to participate, 6 were dead or had moved while 4 were
unknown. One was later excluded due to missing data
(see Figure 1). Thus, n = 29 were included in the 14 years
FU analyses.
Procedure
A signed informed consent to participate was obtained
before the patients scored their current pain twice in a
30 minutes interval (mean VAS) within a family doctorExcluded: 5 did not meet the 







Lost to Follow-up: 6 were dead or 
had moved, 15 refused to participate,
4 unknown (n= 25)
Excluded from analysis 
because of missing 
baseline data (n = 1)
Table 1 Explanatory variables considered in the analysis
Variables
regarding











Factor Use of amitriptyline (no, yes).
Use of guided imagery (0 = none,
1 = visualization of landscape,
2 = visualization of pain control)
Personality,
cluster- c
Numerical Avoidant personality traits (MCMI-I)
Dependent. personality traits (MCMI-I)
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were scored. Thereafter, they re-scored pain twice in
their home context (Pain HC) one hour later. Following
30 days using amitriptyline/placebo medication and/or
guided imagery/control programs, they measured
post-score pain [18]. After these 30 days there were
no active or passive interventions or attention from
the experimentalists before the FU 14 years later.
Then, the FM patients were contacted by mail and
phone for FU examinations. They signed new informed
consents before they re-scored pain (Pain FU) to the
same doctor as at baseline. This trial has been in
compliance with the Helsinki Declaration and
approved by the local ethics committee of Mid-
Norway (Regional Ethics Committee number: 181–04)
as well as the Norwegian Social Science Data Services,
NSD (number: 11541).OCD personality traits (MCMI-I)Instruments
This follow-up study followed a guided imagery interven-
tion only 30 days after baseline [18,40] before a natural
course the subsequent 14 years.Assessments
In 1991, the participants scored pain by a visual
analogue scale (VAS) in two social contexts, i.e. initially
in a doctor context (Pain DC) and subsequently in the
home context (Pain HC) the same day. 14 years later
54.5% re-scored pain in the doctor context (Pain FU),
see Figure 1.
A VAS scale for pain has shown to be reliable and
valid [41], it ranges from 0–100 from zero to maximal
pain, and it is recognized as sensitive to change [42]. At
baseline participants also completed the Beck Depres-
sion Inventory (BDI), which is a 21-item self-report in-
ventory designed to assess affective, behavioural,
cognitive, motivational and vegetative aspects of depres-
sive symptoms [43]. It has been shown to be a valid
measure of depression, especially for the actual day of
measurement [44]. Anxiety was measured by the State-
Trait Anxiety Inventory-Trait (STAI-T), which consists
of a set of 20 statements in which the respondent rates
how anxious he/she feels on a four-point scale. Total
scores range from 20 to 80 with high scores indicating
a higher anxiety. The reliability of STAI-T is well docu-
mented [45]. The Millon Clinical Multiaxial Inventory
(MCMI) was used as a psychological assessment tool to
provide information on personality traits outlined in the
DSM-system, e.g. cluster-c traits. It was developed and
standardized specifically on clinical populations [46].
The variables considered in the study are specified in
Table 1.Data analysis
To examine differences between completers and non-
completers, the significance was based on one-way
ANOVA for the continuous variables and Pearson’s Chi-
square and Fisher exact test for the categorical variables.
To examine the inter-correlations between contextual
and time-dependent pain, i.e. Pain HC (baseline), Pain
DC (baseline) and Pain FU (Pain DC at follow-up), we
used Pearson’s r. Dependent t-test were run to detect
differences in the pain and mood variables (VAS 0–100)
from Time and Context, while Fisher exact test tested
the time effects for the categorical FM tender points
data. In order to assess how the variables were asso-
ciated with pain in the various contexts, linear models
were fitted with pain (DC, HC and FU) as the response
variables. Several explanatory variables obtained at base-
line in the doctor context (DC) were considered
(Table 1), and backwards stepwise regression was used to
select models having a small number of variables.
In the regression model (which allowed categorical
variables as well as numerical variables as explanatory
variables), parameters were estimated by maximum like-
lihood using the glm function in the R system for statis-
tical computation [47]. A backward-stepwise selection of
terms based on F statistics was performed, aided by the
drop term function of the MASS package for R [48].
The least significant term was omitted, and the proced-
ure was repeated until all remaining terms contributed
significantly to the model at the 0.05 level. Significance
for the remaining baseline variables were based on stan-
dardized coefficients, each having a t distribution under
the null hypothesis that the parameter is zero. Models
were selected for doctor contextual pain (Pain DC),
home contextual pain (Pain HC), and pain at follow-up
Table 2 Pain reportings: Descriptives a and correlations b (n = 24)
Mean a ± SEM (SD) Baseline Doctor Baseline Home Follow-up 14 yrs Doctor
Baseline Doctor 50.3c d ± 4.0 21.3 - 0.49b * 0.14 b ns
Baseline Home 38.8c * ± 4.3 23.0 0.49 b * - 0.47b *
Follow-up 14 yrs Doctor 50.2d ± 4.4 23.6 0.14b ns 0.47b * -
a Pain (VAS) descriptives.
b Correlations (Pearson’s r), p values ≤ 0.05 are marked *
c Dependent t-test of group means between baseline pain scores at home vs. in a doctor office; completers (* p<0.05).
d Dependent t-test of group means between pains in doctor’s office with a 14 years’ time lag; completers (ns).
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as an explanatory variable in the initial model.
Results
None of the baseline variables showed any differences
between the completers and the 14 years FU non-
completers on one-way ANOVA for the continuous vari-
ables and Pearson’s Chi-square and Fisher exact test for
the categorical variables. Pain improved with psycho-
logical treatment (guided imagery) after 30 days, as
shown in the original study [18].
Within-groups measures
Pain by context and time (long-term)
55 participants reported pain in both contexts at baseline.
The mean contextual pain (VAS) difference for the com-
pleters (n = 30) at baseline was significant = 11.5 (t = 3.12,
p = 0.004). For the whole sample (n = 55) at baseline,
mean pain (VAS) was also lowest at home, i.e. a difference
= 7.2 (t = 2.36, p = 0.022). Conversely, long-term time did
not influence pain significantly after 14 years, showing a
very small VAS difference from baseline to follow-up = 0.1
(p> 0.05) when measuring the completers in the same
context (i.e. doctor context). See Table 2.
Mood by time
In contrast to pain, depression (BDI) and anxiety (STAI-T)
both improved after 14 years from 16.7 to 12.5 (difference
= 4.2) (t = − 2.52, df = 27, p < 0.05) and from 51.1 to 41.0 =
10.1 (t = −5.21, df = 27, p < 0.0001), respectively.
Tender points by time
Five out of 29 subjects (17.2%) had less than 11 of 18
tender points after 14 years, and thus did not fulfill to
have FM anymore. Fisher's Exact Test for the count
data indicated a significant change, p-value = 0.02;Table 3 Model of predictors of pain at baseline (VAS) in doct
Parameter corresponding to Estimate
Intercept - 9.23
Insomnia (VAS 0–100) 0.33
Anxiety (STAI-T) .86alternatively a true odds ratio is less than 1, with 95
percent confidence interval: 0.00-0.73.
Correlations
The correlation between the two contextual dependent
pain recordings Pain HC (baseline), Pain DC (baseline)
was significant (r = 0.45), while the correlation between
the two time dependent pain recordings Pain DC at
baseline and Pain FU (Pain DC at follow-up) was not
(r =0.14). See Table 2:
Associations and predictor analyses
Baseline pain DC was positively associated with baseline
trait anxiety (STAI-T) and insomnia scores. See Table 3.
Baseline Pain HC was positively associated with baseline
Pain DC, while amitriptyline appeared as a resilience
factor. See Table 4.
Prediction of follow-up pain (Pain FU 14 years) from
baseline variables showed that single-status, depression,
long pain-duration and obsessive compulsive personality
traits seemed to predict worse pain at follow-up 14 years
ahead, while education and guided imagery coping strat-
egies apparently predicted less pain, see Table 5:
Discussion
Mean pain was worse to a doctor than at home the same
day, but appeared unchanged after 14 years in the same
context. The pain recordings at the doctor’s office were
not significantly correlated, indicating that pain was not
stable within individuals, and our findings suggest that
some factors may explain the individual differences for
pain in context and time.
Pain measured to the doctor was positively associated
with the trait-anxiety (STAI-T) and insomnia measures
at baseline, findings which are in accordance with other
studies about pain and anxiety [49]. For blood-pressure
measurements, which tend to be higher to a doctor thanor context from other baseline parameters, n = 26
Std. Error t value Pr(> | t |)
19.81 - 0.47 0.65
0.14 2.4 0.03
0.40 2.16 0.04
Table 4 Model of predictors of pain at baseline (VAS) in home context from other baseline parameters, n = 27
Parameter corresponding to Estimate Std. Error t value Pr (> | t |)
Intercept 5.1143 9.0610 0.564 0.58
Pain in doctor context, Pain DC 0.7586 0.1645 4.611 0.00012
Amitriptyline −18.952 7.8361 −2.419 0.02
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previous visits to the physician’s office probably has an
effect on subsequent recordings [26]. Previous research
supports our findings that insomnia is associated with
FM pain in the short-term perspective [3]. Until recently,
it has been unknown whether poor sleep contributes to
FM in the long-term. In a new study by Mork & Nilsen,
sleeplessness predicted fibromyalgia during 10 years in a
previous healthy population [50].
When pain was measured at home the same day,
previous pain mattered for pain worsening, a finding
in accordance with other studies [13,51], while amitrip-
tyline appeared as a resilience factor. Some analogue
studies have shown that drug-effects may depend on
their context, the so called place preference or place
aversion (classical) conditioning [33,52].
Baseline depression, long pain-duration, being single
and OCD-traits were associated with worse pain 14 years
ahead. These findings support previous literature that
depression is a risk factor for long-term FM symptoms,
e.g. [14]. However, depression may act both as a risk fac-
tor and a consequence of pain [53] and vary with third
factors [54,55]. Self-critical perfectionism, an active
generation of stress, stress sensitivity and levels of de-
pression are features which may explain the association
between OCD and forthcoming pain [56]. In contrast,
education seemed to be a resilience factor for future
pain in our study, a finding in accordance with previ-
ous findings that FM patients have lower educational
level than non-patients, e.g. [57]. Guided imagery also
appeared as a resilience factor in this 14 years follow-
up of the Fors et al. 2002 study [18], which supportsTable 5 Model of predictors of pain at follow-up (VAS) after 1
N = 26







Guided Imagery1 - 46.95
Guided Imagery2 - 16.62
OCD personality traits 1.04findings that relaxation, imagery and cognitive training
may predict reductions in pain compared to untreated
patients [58]. Syrjala et al.[59] and van Kuiken et al.
[60] have revealed results which show that guided im-
agery have positive effects the first five to seven weeks
after treatment, but that the effects seem to yield after
18 weeks [61] in reducing persistent pain [19,62], but
it has not been investigated in a long-term prospective
studies previously.
This study brings new information about how pain
vary with context among patients with FM. A strength
of the study was that pain was measured in two different
contexts the same day and two similar contexts with
long term follow up.
Several limitations of this study needs to be addressed:
The statistical model used for associations and predic-
tion of pain (in a doctor context, in a home context, and
in a doctor context after 14 years) was an ANCOVA lin-
ear regression model, which was fitted to the data using
a backwards stepwise selection using F-tests with 0.05 as
critical value, so that we ended up with a model where
each covariate was significant in presence of the others.
The low number of participants (n = 29), leading to low
power may have prevented discovery of potential predic-
tors. Also, the strict significance level of 0.05 may have
possibly omitted important predictors from the models.
On the other hand, the multiple testing procedure to se-
lect covariates in stepwise regression in general may lead
to too small p-values and possibly false findings. Hence
the findings may be regarded as hypothesis-generating
findings more than true predictions. There was great in-
dividual variability among the pain sufferers, which may4 years in a doctor context from the baseline parameters,




0.22 - 2.51 0.023
0.59 2.15 0.046
0.48 2.45 0.026
10.41 - 4.51 0.00031
9.03 - 1.84 0.08 ns.
0.48 2.17 0.04
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dict future pain. Another weakness in the study was that
the frequency of the guided imagery use was not mea-
sured, so the effect of this intervention may be spurious.
Another possible limitation of our study was the meas-
urement of just current pain. In chronic pain studies
many investigators measure pain scores as the mean
sum of current+ last week + maximal + minimal pain, as
seen in e.g. the Brief Pain Inventory [63]. However, we
would expect a current pain measure to be more sensi-
tive to variations in context than an aggregated measure
of pain. Thus, contextual pain cues should be accounted
for when pain is monitored and treated, e.g. by focusing
more on home-measured pain and doctor office context.
Conclusion
Our study suggests that contexts should be accounted
for when reporting current pain. It seems to matter
where and how the pain is recorded. Our study also sug-
gests that the factors explaining the variance in pain
may vary by contexts. The implication of our findings
would advocate a new approach to pain by focusing
more on home-measured pain and modifying the context
or environment of the doctors’ office if possible, e.g. to
emphasize comfort and empathy more [64] in order to
reduce pain.
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